Literature DB >> 8999550

Reverse transcriptase fidelity and HIV-1 variation.

W Keulen, M Nijhuis, R Schuurman, B Berkhout, C Boucher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8999550

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  11 in total

Review 1.  Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".

Authors:  Kimberly A Schoenly; David B Weiner
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

2.  Genome-wide comparative analysis of copia retrotransposons in Triticeae, rice, and Arabidopsis reveals conserved ancient evolutionary lineages and distinct dynamics of individual copia families.

Authors:  Thomas Wicker; Beat Keller
Journal:  Genome Res       Date:  2007-06-07       Impact factor: 9.043

3.  Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Authors:  Michael E Abram; Andrea L Ferris; Kalyan Das; Octavio Quinoñes; Wei Shao; Steven Tuske; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

4.  Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro.

Authors:  W C Drosopoulos; V R Prasad
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  N K Back; B Berkhout
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.

Authors:  Susan M Schader; Susan P Colby-Germinario; Peter K Quashie; Maureen Oliveira; Ruxandra-Ilinca Ibanescu; Daniela Moisi; Thibault Mespléde; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

7.  Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.

Authors:  B B Oude Essink; N K Back; B Berkhout
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

8.  Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.

Authors:  Shuping Wang; Rico Buchli; Jennifer Schiller; Jianen Gao; Rodney S VanGundy; William H Hildebrand; David D Eckels
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

9.  HIV-1 tolerates changes in A-count in a small segment of the pol gene.

Authors:  Bep Klaver; Yme van der Velden; Formijn van Hemert; Antoinette C van der Kuyl; Ben Berkhout
Journal:  Retrovirology       Date:  2017-09-05       Impact factor: 4.602

10.  Characterization, Genomic Organization, Abundance, and Chromosomal Distribution of Ty1-copia Retrotransposons in Erianthus arundinaceus.

Authors:  Yongji Huang; Ling Luo; Xuguang Hu; Fan Yu; Yongqing Yang; Zuhu Deng; Jiayun Wu; Rukai Chen; Muqing Zhang
Journal:  Front Plant Sci       Date:  2017-06-07       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.